Vascular Biogenics Ltd (VBLT)

[Oren1976]

I think the phase 3 is not similar to ph2. I won't be surprised to see a huge failure or very weak results. How stupid can the company be to design a different trial while they have a successful phase 2 in hand that u only need to repeat it. Unfortunately the avastin will kill the patients in both arms not letting the vb111 express itself are much less than it should be. The complete responder u were talking about stopped being a complete responder because of the avastin if the vb111 was given to him as mono like the phase 2 he would have still be complete responders. The avastin provoke the cancer making him much much more aggressive and deadly. Even a donkey understand that and many of the patients and doctors. Vbl is a huge disappointment not repeating the phase 2 with no changes.